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Abstract 
Autosomal dominant polycystic kidney disease (ADPKD), is caused by inactivating 
mutations in PKD1 (85%) or PKD2 (15%). The ADPKD proteins, polycystin-1 (PC1) and 
polycystin-2 (PC2) form a plasma membrane receptor-ion channel complex. However the 
mechanisms controlling the subcellular localization of PC1 and PC2 are poorly understood. 
The retromer complex is an ancient protein module initially discovered in yeast that 
regulates the retrieval, sorting and retrograde transport of membrane receptors. Here, we 
report for the first time that PC1 and PC2 are retromer cargos, whose surface expression 
and function are regulated by a sorting nexin 3 (SNX3)-retromer complex. Two SNX-3 
isoforms, one novel, with distinct binding properties to PC2, were identified though yeast-
2-hybrid, biochemical and cellular assays. Knockdown of SNX-3 or the core retromer 
protein VPS35 resulted in an increased surface expression of endogenous PC1 and PC2 in 
vitro and in vivo with evidence of increased Wnt-activated endogenous PC2-dependent 
whole cell currents. Molecular targeting of endosomal sorting of PC1 and PC2 could lead 
to new therapeutic approaches in ADPKD. 
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Introduction 
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited 
renal disease. It is a major cause of end-stage renal disease (ESRD) worldwide and 
accounts for ~10% of all patients on renal replacement therapy 1. ADPKD is caused by 
germline mutations in PKD1 (type 1 ADPKD) or PKD2 (type 2 ADPKD) genes. The 
ADPKD proteins, polycystin-1 (PC1 or PKD1) and polycystin-2 (PC2, PKD2, or TRPP2) 
form a heterodimeric protein complex which is essential for maintaining tubular 
differentiation, polarity and diameter 2. 
  
Despite the demonstration of a PC1-PC2 complex in heterologous or native systems3-5, the 
subcellular localization of both proteins only overlaps in a few domains of the plasma 
membrane or the primary cilium 6. Some studies have reported that PC2 can function 
independent of PC1 as a cell surface receptor-operated Ca2+-permeable channel complexed 
with other members of the TRP superfamily of ion channels such as TRPC1 7, TRPV4 8, 9 
or both 10. We recently reported that the cell surface pool of PC1/PC2 in mouse embryonic 
fibroblasts and transfected CHO-K1 cells can be activated by Wnt proteins, suggesting that 
the PC1/PC2 complex can function as a ligand activated channel complex 11. In addition to 
the cell surface pool of PC2, the majority of PC2, but not PC1, can be detected in the ER 4, 
12
, where it enhances ER Ca2+ release in response to G protein coupled receptors linked to 
the production of IP3 as a second messenger 13, 14. Therefore, PC2 is likely to have multiple 
roles in Ca2+ signaling depending on its subcellular localization, particularly in relation to 
PC1 3, 4, 12, 15-18. 
 
Here, we report for the first time that PC1 and PC2 are retromer cargos and the surface 
expression of PC2 is regulated by distinct SNX3 isoforms at the stages of clathrin-mediated 
endocytosis (SNX3-102) and retrograde transport and sorting (in case of the classical 
SNX3-162 and VPS35) in the endosomal pathway. 
 
Results 
SNX3-102, a novel SNX3 isoform, is a new interacting partner of PC2 
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To identify novel regulators of PC2 sorting and trafficking, we performed a yeast-2-hybrid 
(Y2H) screen of a mouse E17 cDNA library using a region (aa799-895) of the PC2 C-
terminus (CT2) as bait. This region contains several important functional motifs including 
several important serine phosphorylation residues (Ser801, Ser812, Ser829), a coiled-coil 
domain (CC2, aa833-871) essential for CT2 dimerisation and interaction with the C-
terminus of PC1 (CT1) and a heterodimerisation sequence (aa871-895) for PC1 binding 5, 
17, 19
. Among several positive interactors (data not shown), we identified SNX3-102, a 
novel isoform of SNX3. We confirmed its interaction to CT2 (aa 680-968) in directed 
yeast-2-hybrid assays (Fig 1a). Mutation of CC2 (4M) which disrupts CT2 dimerization 
and PC1 recognition 5, however had no effect on binding. Interestingly, CT2 did not bind 
to the classic SNX3 isoform (SNX3-162, isoform 1) (Fig 1a). To confirm that the 
interaction between SNX3-102 and CT2 was direct, we carried out in vitro GST pull-down 
assays using recombinant GST-SNX3 and Thio-CT2 proteins. Consistent with yeast 2-
hybrid assays, GST-SNX3-102 but not GST-SNX3-162 showed direct binding to both 
Thio-CT2 (799-871) (not shown) and Thio-CT2 (680-968) (Fig 1b). 
 
Sequence analysis revealed that compared with SNX3-162, SNX3-102 lacked exon 3 and 
a part of exon 4 due to alternative splicing at a cryptic splice site (Fig 1c, Supp Fig 1). This 
deletes most of the PX domain (aa27-151). Since four other SNX3 isoforms have 
previously been reported, we have named this new isoform as isoform 5. Q-PCR analysis 
of developing mouse embryos (E10-E16) and a number of mouse and human kidney cell 
lines confirmed that SNX3-102 is widely expressed but at much lower levels (3-5%) 
relative to SNX3-162 (Fig 1d) or other kidney cell lines (Supp Fig2c).  
 
The disrupted PX domain in SNX3-102 cannot mediate phospholipid binding 
We next performed co-immunoprecipitation experiments to confirm the interactions 
between full-length SNX3-102 and PC2. Using HEK293 cells, SNX3-102 co-
immunoprecipitated with PC2 (Fig 2a). Unexpectedly, binding was also observed with 
SNX3-162 (Fig 2a). This raised the possibility of an indirect interaction or binding to a 
different domain of PC2. To better understand this discrepancy, we decided to better 
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characterise SNX3-102. SNX3-162 has been shown to be recruited to endosomes in a 
PtdIns(3)P dependent manner 20. Binding has been demonstrated to be mediated by a PX 
domain though evidence of a second non-canonical PtdIns(3)P binding site in the C-
terminus (aa147-162) has also been reported 21. To determine whether the missing exons 
in SNX3-102 were functionally important for phospholipid binding, protein-lipid overlay 
assays were carried out using commercial lipid strips. As predicted, GST-SNX3-162 bound 
strongly to PtdIns(3)P and weakly to PtdIns(5)P (Supp Fig 2a). In contrast, GST-SNX3-
102, showed no lipid binding under the same conditions. These results are in line with the 
hypothesis that the intact PX domain is essential for phospholipid binding (and endosomal 
recruitment). Thus SNX3-102 is likely function in a different compartment from that of 
SNX3-162. 
 
The subcellular localization of SNX3-102 and SNX3-162 are distinct  
Expression of GFP-tagged SNX3 isoforms in several cell lines revealed a striking 
difference in their localization. GFP-SNX3-162 showed a strong overlapping distribution 
to EEA1-positive early endosomes whereas GFP-SNX3-102 co-localized with adaptor 
protein-2 (AP2) which is enriched in clathrin-coated endocytic vesicles (Fig 2b). 
Consistent with this, we observed GFP-SNX3-102 expression at or close to the plasma 
membrane in the majority (70% or more) of transiently transfected cell lines including 
HeLA, MDCK, LLC-PK1 and IMCD3 (Fig 2b and data not shown). Taken together, these 
results suggest that SNX3-102 could be involved in AP2 or clathrin mediated endocytosis 
of PC2 whereas SNX3-162 is involved in its retrograde transport and sorting in early 
endosomes. GST pull-down assays from HEK293 using co-expressed GST-SNX3-102 
revealed specific interactions with endogenous clathrin heavy chain (CHC) and the AP2 
ȝ (AP2M1) subunit (Fig 2c). In contrast, GST-SNX3-162 did not interact with either 
protein consistent with its localization to early endosomes. 
 
The retromer complex protein VPS35 binds directly to the N-terminus of PC2 
Since SNX3-162 was localized to early endosomes and could associate with full-length 
PC2, we investigated the possibility that it could bind to either N- or C-terminus of PC2 
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(NT2 or CT2) indirectly via the retromer complex. The retromer complex originally 
identified in yeast comprises two sub-complexes: a trimer (Vps26-29-35) which functions 
as a cargo-selective adaptor and a membrane deforming sub-complex consisting of a SNX-
BAR heterodimer. We found that the full-length HA-PC2 and GFP-VPS35 proteins co-
immunoprecipitated when expressed in HEK293 cells (Fig 2d) and confirmed that 
endogenous PC2, VPS35 and SNX3-162 were present in the same complex in LLC-PK1 
cells (Fig 2e). Significantly, knockdown of endogenous VPS35 abolished the binding 
between PC2 and SNX-162 in LLC-PK1 (Fig 2f, Supp Fig 2e). To define the binding 
domain in PC2 mediating the interaction with VPS35, GST pull-down assays from whole 
cell extracts were next performed. This revealed a clear interaction between GFP-VPS35 
and GST-NT2 (aa1-223) but not with GST-CT2 (aa680-968) (Fig 2g). Finally, we 
confirmed that the interaction between NT2 and VPS35 was direct using a recombinant 
protein containing the entire VPS35, VPS26 and VPS29 trimer (Fig 2h). 
 
To investigate whether the involvement of the retromer complex in PC2 trafficking could 
be extended to PC1, we investigated the interaction between VPS35 and the C-terminus of 
PC1 (CT1). In HEK293 cells, binding between GFP-VPS35 and GST-CT1 (aa4107-4303) 
was detected (Fig 2g). Similar to NT2, we confirmed a direct interaction between 
recombinant MBP-CT1 and the FLAG-VPS35/26/29 proteins in vitro (Fig 2i). 
Interestingly, co-immunoprecipitation could not be confirmed between GFP-VPS35 and 
full-length PC1 (not shown) suggesting that the interaction between the full-length proteins 
could be conformationally restricted or depend on the presence of PC2 in vivo. Our results 
however are consistent with PC2 being a direct retromer cargo.  
 
Knockdown of SNX3 or VPS35 increases PC2 surface expression 
Since our data suggested a potential role for SNX3 in the recycling of plasma membrane 
PC2, we hypothesised that knockdown of endogenous SNX3 would affect the surface 
expression of endogenous PC2. In previous studies, we and others had shown that in kidney 
epithelial cells, the vast majority of PC2 is localized in the ER, but a small percentage of 
PC2 (less than 10%) can be detected at the plasma membrane and ciliary membrane 4, 7, 18, 
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22
. This cell surface pool of PC2 is functional, since it has been shown to contribute to basal 
conductance and can be further activated by EGF, G protein coupled receptor agonists 23 
and Wnt ligands 11 in diverse cell types.  
 
Efficient knockdown of both SNX3 isoforms was achieved using sequence specific siRNA 
in LLC-PK1 cells (Supp Fig 2b,d). As the endogenous expression of SNX3-102 was not 
easily detectable by immunoblotting, we confirmed knock-down of this isoform at the 
mRNA level by semi-quantitative RT-PCR using isoform specific primers (Supp Fig 2b). 
Significantly, we observed an increase in surface PC2 and PC1 following SNX3 
knockdown by both surface biotinylation (Fig 3a,b) and of PC2 by immunofluorescence 
labelling (Fig 3d,e). Unfortunately, increased cell surface expression of endogenous PC1 
by indirect immunofluorescence could not be achieved, because several available PC1 
antibodies did not work in this assay. However, deglycosylation analysis of surface labelled 
PC1 and PC2 complex confirmed that surface labelled PC1 was EndoH-resistant whereas 
labelled PC2 remained fully EndoH-sensitive (Fig 3c). As expected, the membrane protein 
Na+ K+ ATPase was EndoH-resistant in the same assay (Fig 3c). 
 
To substantiate our findings, we next depleted endogenous VPS35 by siRNA. Similar to 
SNX3, this resulted in a marked effect on surface PC1 and PC2 expression by surface 
biotinylation (Fig 3a,b) and of PC2 by immunofluorescence labelling (Fig 3d,e). This effect 
was even more pronounced than the knockdown of SNX3 (both isoforms). Finally, we did 
not observe detectable changes in ciliary expression of PC2 following knockdown of SNX3 
or VPS35 (Fig 3d). Taken together, these results suggest that PC2 and PC1 recycling to the 
plasma membrane is likely to be mediated to a large extent by the SNX3-162-VPS35 
interaction at the level of early endosomes. 
 
Knockdown of VPS35 in Xenopus embryos increases PC2 surface expression in 
pronephric kidney tubules 
To examine whether inhibition of the retromer complex had a similar effect on PC2 
localization in vivo, we turned to Xenopus as a model for PKD 24, 25. In Xenopus, PC2 is 
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expressed along the entire length of the pronephric kidney and the protein can be detected 
by immunofluorescence confocal microscopy both at the cell membrane and the apical cilia 
(Fig 3f, Supp Fig 3a) 24. To inhibit the retromer complex, embryos were injected at the 2-
cell stage with an antisense morpholino oligomer targeting VPS35 (VPS35-MO), which 
has been characterized previously 26. At late tail bud stage, knockdown of VPS35 
confirmed at the protein level (Supp Fig 3c) resulted in increased staining for PC2 protein 
in kidney tubules at the cell membrane both apically and basolaterally (Fig 3f). This was 
confirmed by quantification of the apical PC2 signal in the proximal tubules using 
counterstaining with Erythrina Cristagalli Lectin (ECL, Fig 3g). Finally, as expected from 
the ubiquitous expression of Vps35, the upregulation of PC2 protein was not limited to the 
pronephric kidney only, but was also be observed in other tissues expressing PC2 (e.g. 
notochord, data not shown).  
 
Knockdown of VPS35 increases Wnt activated PC2 whole cell current density 
Next, we tested whether retromer function could regulate Wnt activated PC2-dependent 
Ca2+ signaling. In a recent paper, we showed that purified Wnt9b induced large PC2-
dependent whole cell currents in mouse embryonic fibroblasts (MEFs) and transfected 
CHO-K1 cells 11. Here, we tested whether Wnt9b could also induce endogenous PC2-
dependent whole cell currents in LLC-PK1 cells. We confirmed that LLC-PK1 expressed 
endogenous PC1 (Supp Fig 4a) and responded to Wnt9b in a dose-dependent manner. Time 
course experiments using purified Wnt9b (12.5 nM for a 40 kDa protein) induced time-
dependent and La3+-inhibited whole cell currents (Fig 4a-c). Dose-response experiments 
indicated that Wnt9b or Wnt5a activated whole cell inward (-100 mV) and outward (+100 
mV) currents with values ranging from 45 to 76 ng/ml (Supp Fig 4b). This effect was 
dependent on endogenous PC2 as knockdown of PC2 completely suppressed the response 
to Wnt9b 27. (Fig 4d-f). 
 
Upon depletion of VPS35, Wnt9b (500 ng/ml) induced whole cell current density was ~2-
fold larger (Fig 4g-i) than current density induced by Wnt9b in mock-transfected cells (Fig 
4a-c). To test whether PC2 contributed to Wnt9b-induced currents in VPS35-depleted cells, 
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PC2 was downregulated together with VPS35. Doubly-transfected cells showed 
diminished response to Wnt9b (Fig 4j-l), indicating that the increased magnitude in Wnt9b-
induced currents in VPS35-depleted cells was due to a specific upregulation of plasma 
membrane PC2. Wnt5a showed a similar effect to Wnt9b (Supp Fig 4b). Summary data for 
inward and outward current densities are shown in Fig 4 (m, n). Because VPS35 
knockdown could potentially affect the trafficking of other channels to and from the plasma 
membrane, we compared cell capacitance in mock and VPS35-depleted cells. We however, 
could not record a measurable difference in total cell capacitance between the two cells 
types (Fig 4o) indicating that depletion of VPS35 did not have a substantial effect on the 
trafficking of other channels to and from the plasma membrane. We were unable to test the 
effect of SNX3 knockdown on PC1/PC2 channel activity as whole cell currents were 
unstable for electrophysiology experiments. Overall, these studies showed that depletion 
of VPS35 did not only increase the cell surface expression of PC2 protein, but also PC2-
dependent whole cell currents.  
 
Discussion 
The SNXs are a family of proteins first identified in yeast which share a Phox (PX) domain 
with affinity for PtdIns(3)P. In mammals, at least 33 SNXs have been identified 28. In yeast, 
the best characterized function of the retromer complex is to regulate retrograde transport 
of cytosolic proteins from late endosomes to the TGN (trans-Golgi Network). In 
mammalian cells however, the functions of the retromer complex are now thought to be 
broader since components of the retromer complex are found throughout the endosomal 
network (including clathrin-coated vesicles) 29, early endosomes (EGF receptor retrieval) 
20, 30
 with enrichment in sorting endosomes where decisions on the fate of endocytosed 
cargo towards rapid recycling (to the plasma membrane), degradation (in lysosomes) or 
recycling (via the TGN) are made. Recently, a non-classical retromer complex consisting 
of the VPS26-29-35 trimer associated with monomeric SNX3 (rather than with a SNX-
BAR heterodimer) was reported 31, 32. This SNX3 retromer was shown to be essential for 
Wnt secretion in C. elegans and D. melanogaster through regulating the retrograde 
transport of Wntless and was preferentially localized in early endosomes rather than sorting 
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endosomes where SNX-BAR retromer complexes are enriched 32. This spatial segregation 
could favor sequential cargo handling between both retromer complexes. Our discovery of 
a novel SNX3 isoform (SNX3-102) refines the role for SNX3 in this pathway by linking 
clathrin-mediated endocytosis to early endosomes (Figure 5). 
 
Here we report for the first time that PC1 and PC2 are hitherto unrecognized cargos of a 
SNX3-retromer complex and demonstrate that VPS35 regulates the surface expression of 
PC1 and PC2 in vitro and in vivo. An initial yeast-2-hybrid screen using the C-terminus of 
PC2 as bait identified a novel isoform of SNX3 as a direct PC2 binding partner. We have 
named this isoform 5. The new isoform (SNX3-102) is likely to be generated by alternative 
splicing since it excludes exons 3 and part of exon 4 and consequently lacks most of the 
predicted PX domain found in the classical isoform 1 (SNX3-162). However quantitative 
gene expression analysis has shown that it is expressed at much lower levels (5%) 
compared to isoform 1. Strikingly, SNX3-102 was predominantly localized to clathrin-
coated vesicles, where it co-localized with AP2. This is in contrast to SNX3-162 which 
was predominantly localised in EEA-1 positive early endosomes. Based on our interaction 
studies, these findings suggest that PC2 is endocytosed by clathrin-AP2 mediated binding. 
This observation was confirmed by the fact that SNX3-102, but not SNX3-162 bound to 
the endogenous clathrin heavy chain (CHC) and the AP2 P (AP2M1) subunit in HEK293 
cells. However, our results do not exclude possible roles for the other SNX3 isoforms 
(isoforms 3 and 4 but not 2) which would also have been targeted by the SNX3 siRNA 
used (Fig 1c).  
 
Importantly, we showed that LLC-PK1 cells depleted of VPS35 showed an increase in 
Wnt9b-induced current density directly proportional to the increase in the cell surface 
expression of endogenous PC2 in these cells. Given the fact that PC2 cannot form a Wnt-
activated channel without PC1, our data indicate that the limiting factor in PC1/PC2 
channel function is PC2 in LLC-PK1 cells. Despite significant efforts, we could not obtain 
stable currents in cells depleted of SNX3, suggesting that structural changes in the plasma 
membrane could have affected the quality of the plasma membrane required for reliable 
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current measurements. 
 
An important observation was that the SNX3-retromer complex regulated surface 
expression and function of PC1 and PC2 at the plasma membrane but did not regulate cilia 
localization of PC2 and by inference the function of the cilia PC1/PC2 complex. This is 
not unexpected since distinct mechanisms regulating the forward trafficking of PC2 to 
either cilia or plasma membranes have also been described 33. Whilst there is agreement 
that PC2 is present in several subcellular compartments such as the ER, endosomes, 
basolateral plasma membrane and ciliary membrane, there is inconclusive evidence that an 
exclusive function in any one compartment (including primary cilia) is sufficient to prevent 
cystogenesis 2, 5, 34. Indeed, reduced cilia PC2 due to impaired Golgi sorting (GMAP210 
null mice) 35, 36 or absent cilia PC1 due to defective PC1 cleavage (Pkd1v/v mutant mice) 37, 
38
 did not result in an early-onset PKD phenotype in vivo suggesting that different 
functional pools of the PC1/PC2 complex are important during kidney development, in 
different tubular segments 37 and by inference, in the mature organ 34. In addition, since our 
experiments were not conducted under conditions that promoted optimal cilia formation, it 
is probable that the Wnt-activated Ca2+ currents we measured can be attributed to plasma 
membrane PC1/PC2 and not the cilia PC1/PC2 complex. This is in agreement with recent 
work suggesting that the PC1/PC2 cilia signal is unlikely to be activated either by flow or 
mediated by Ca2+ 39. Also, since we were unable to identify an EndoH-resistant PC2 cilia 
fraction reported by one group 38, our observations are most likely relevant to the plasma 
membrane PC1/PC2 fraction 4, 40. 
 
In summary, our results support a sequential model where SNX3-102 first regulates PC2 
endocytosis by directly binding PC2 and AP2/clathrin to cluster PC2 in clathrin-coated 
vesicles before relaying it to early endosomes where SNX3-162 and VPS35 regulate its 
sorting and fate, together with that of PC1 (Fig 5). In a recent paper, we have reported an 
alternative pathway for PC1/PC2 endocytosis via an AP2/ARBB1 mechanism mediated by 
direct binding to the PC1-PLAT domain; here however, endocytosis from plasma 
membrane and cilia membranes were similarly affected and dependent on PKA-
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phosphorylation of PLAT at a specific residue (Ser3164) 41. The precise relationship between 
these two retrieval pathways is unclear but likely represent both constitutive (VPS35-PC2) 
and regulated (ARBB1-PC1) mechanisms. In any case, we suggest that that a disruption in 
retrograde transport to the TGN and possibly clathrin-mediated endocytosis leads to 
increased surface delivery of PC1 and PC2 by promoting rapid recycling from early 
endosomes. Finally, our study could have potential therapeutic applications. It is possible 
that compounds that down-regulate SNX3 or VPS35 expression or which inhibit their 
recruitment or function 21, 30 could have therapeutic benefit in ADPKD patients with 
hypomorphic mutations by enhancing PC1/PC2 surface expression. 
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Materials and methods 
All chemicals were purchased from Sigma (Poole, UK) unless otherwise stated. Antibodies 
were purchased from the following suppliers: Mouse anti-Thio (Invitrogen), Mouse anti-
GST (Serotec), Mouse anti-Clathrin HC (BD Biosciences), Rabbit anti-SNX3 (Abcam), 
Mouse anti-EEA1 (BD Biosciences), Goat anti-PC2 (G20) (Santa Cruz), Mouse anti AP2 
ȝVXEXQLW$3%'%LRVFLHQFHV5DWDQWL-HA (Roche), Rabbit anti-HA (Santa Cruz), 
Rabbit anti-c-Myc (Santa Cruz), Rat anti-c-Myc (Serotec), Mouse anti-Pk/V5 (Serotec), 
Mouse anti-Flag (Sigma) and Mouse anti-MBP (NEB). The AP2 mAb (AP6) was the kind 
gift of E. Smythe (University of Sheffield). Purified Wnt9b and Wnt5a were obtained from 
R&D in the carrier-free formulation. 
 
pET23d-3xFLAG retromer (FLAG-VPS35-26-29-His) and pIRES-neo-GFP-VPS35 
plasmids were kind gifts of F. Kishi (Kawasaki Medical School, Okayama, Japan). cDNA 
of SNX3-162 and a C-terminal EGFP vector (pDG0) were gifts of E. Kiss-Toth (University 
of Sheffield) and K. Ross (Liverpool John Moores University, Liverpool, UK). 
 
DNA constructs and site-directed mutagenesis.  
Unless otherwise stated, the PKD2 and PKD1 plasmids used in this paper have been 
previously reported. N-terminal c-Myc tagged SNX3-102 and SNX3-162 constructs were 
generated by PCR and ligation into pcDNA3. GFP-tagged SNX3-102 and SNX3-162 were 
prepared by TOPO cloning into the Gateway® vector pD-G0. SNX3-102 and SNX3-162 
were subcloned into pGEX-6P-1 or pEBG vectors to express N-terminal bacterial or 
mammalian GST-fusion proteins respectively. Similarly, NT2 (PKD2 aa1-223), CT2 
(PKD2 aa680-968) and CT1 (PKD1 aa4107-4303) were subcloned into pEBG to express 
GST fusion proteins in mammalian cells. Site specific mutations were introduced using the 
Quick-change site-directed mutagenesis protocol (Stratagene) as previously described and 
verified by sequencing. 
 
Yeast Two-Hybrid assays 
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A region of the PC2 C-terminus (CT2 799-895) was cloned into the bait vector pGBKT7 
(Clontech) as previously reported 5. This was transformed into the yeast strain AH109 
(containing ADE2, HIS3 and LacZ reporter genes under the control of the GAL4 UAS) and 
used to screen an E17 mouse cDNA library pre-transformed in the yeast strain Y187 
(Clontech). Screening was performed by a yeast-mating method using the yeast strains 
$+ 0$7D DQG < 0$7Į Reporter genes HIS3 and ADE2 and LacZ were 
employed for triple selection of positive transformants. Directed yeast 2-hybrid assays 
were carried out by co-transforming bait and prey plasmids into AH109 as previously 
described 42. The plasmids pGBKT7-53 (p53) and pGBADT7-T (SV40 T-antigen) were 
used as a pair of positive controls. The PC1 and PC2 truncated constructs pGBAD-B-CT1 
(4107-4227) and pACT2-B-CT2 (680-742) were used as a pair of negative controls as 
previously reported. 
 
Recombinant protein preparation  
Plasmids were transformed into the E. coli strain BL21-RIPL and recombinant protein 
expression was induced at 37°C for 3 h with 0.5mM IPTG. Expression and purification of 
the FLAG-tagged retromer complex was performed as previously described 43. GST fusion 
proteins and His-tagged proteins were purified with Nickel or Glutathione-Sepharose 
columns respectively as previously described 5. 
 
GST pull-down assays 
1-ȝJRIWKHEDFWHULDO*67IXVLRQSURWHLQDQGWKH+LV-Thio tagged potential partner protein 
(1-ȝJZHUHLQFXEDWHGLQȝOELQGLQJEXIIHUî7%67ZLWK7ZHHQIRUK
DW57ZLWKJHQWOHURWDWLRQȝORI*OXWDWKLRQH6HSKDURVH%EHDGV*(+ealthcare) 
was then added and the mixture incubated with rotation for an additional hour. The beads 
were sedimented by centrifugation at 6000 rpm for 2 min and washed up to 6 times with 
1ml volumes of ice-cold PBS. Bound proteins were eluted either using 2ȝORIHOXWLRQ
buffer or by boiling for 5-10 min in reducing sample buffer. The same procedure was 
followed for pull-down of mammalian GST-fusion proteins from cell lysates. Mammalian 
GST proteins bound to glutathione beads were similarly prepared for in vitro binding 
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assays except that the beads were washed up to 6 times with 1ml of ice-cold PBS, 
resuspended in 1xTBST (0.2% Tween20) prior to the addition of recombinant protein. 
Coomassie staining showed that the predominant bands eluted from the beads after 
incubation with cell lysates corresponded to the respective GST fusion proteins. 
 
In vitro MBP pull-down assays 
2µg of MBP or MBP-CT1 and 2µg of recombinant FLAG tagged retromer complex 
(3×FLAG- VPS35, VPS26, VPS29-His6) was added to 300µl of binding buffer (5mM 
HEPES pH7.9, 150mM NaCl, 1.5mM MgCl2, 0.1mM EDTA, 0.1% NP-40) and incubated 
at RT with gentle rotation for 4 h. 60µl of 50% amylose resin was then added and the 
mixture incubated for a further 2 h. The beads were then sedimented by centrifugation at 
4ºC, washed six times with 1.5ml amylose column washing buffer to remove unbound 
proteins. Bound proteins were then eluted from the washed beads into loading buffer and 
clarified supernatants analyzed by SDS-PAGE and western blotting. 
 
Protein-lipid overlay assays 
Commercial lipid strips (Echelon® PIP strips P-6001) were blocked with 1% nonfat-dry 
milk in PBS (pH7.4) for one hour at RT, followed by incubation with recombinant protein 
in 1% nonfat-dry milk in PBS (pH7.4) at 4ºC overnight with gentle agitation. The 
membrane was washed in 1×PBST buffer (0.1% v/v Tween-20) for 3×10 min and bound 
protein detected by immunodetection. 
 
Quantitative Real time-PCR 
Normal mouse embryos (kind gift of A Furley, University of Sheffield) at different 
developmental stages (E10, E12, E14, E16) were pooled (n=3) and homogenized for 
RNA extraction. Total RNA was isolated from the embryos or cultured cells using 
TRIzol® (Invitrogen). Each sample was then treated with Ambion® DNA-IUHH'1DVH
kit to remove contaminating DNA. 0.8ug of DNase digested total RNA was reverse 
transcribed into cDNA using a cDNA reverse transcription kit (AB Applied Biosystems) 
according to the manufactXUHU¶VLQVWUXFWLRQV6SHFLILFSULPHUVZHUHGHVLJQHGWRDPSOLI\
16 
 
SNX3-102 and SNX3-162 independently from human and mouse samples: primer details 
are provided below: 
 
human SNX3(162), forward, ¶-CACTTACGAAATCAGGGTCAAG-¶ 
human SNX3(162), reverse, ¶- GGAACTACGACCTTGCTCT-¶  
human SNX3(102), forward, ¶- CACTTACGAAATCAGGGTCAAG-¶ 
human SNX3(102), reverse, ¶- CTATTATTTCATCCTTGCTCTCTC-¶ 
mouse SNX3(162), forward, ¶- CACCTACGAGATCAGGGTCAAG-¶ 
mouse SNX3(162), reverse, ¶- GGAACTACAACCTTGCTCTCTC-¶  
mouse SNX3(102), forward, ¶- CACCTACGAGATCAGGGTCAA-¶ 
mouse SNX3(102), reverse, ¶- CTATAATTTCATCCTTGCTCTCTC-¶ 
 
Real time PCR was performed using the IQTM Cybr Green system (BioRad). HPRT 
(hypoxanthine guanine phosphoribosyl transferase) was used as housekeeping gene and 
WKHGDWDRI&7YDOXHZDV FDOFXODWHG LQ UHODWLRQ WR+3577RDQDO\]H WKHGDWD D¨¨&W
method was used to calculate the relative mRNA level. 
 
Cell culture and transfection 
HEK-293, IMCD3, MDCKII, Hela and LLCPK cells were cultured in DMEM 
supplemented with 10% fetal bovine serum. Transient transfection was carried out on cells 
cultured to 60-80% confluency using Genejuice transfection reagent (Novagen) or 
/LSRIHFWDPLQH,QYLWURJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV  
 
Protein biochemistry 
Cells were lysed by extraction at 4°C using the IP lysis Buffer (25mM NaCl, 150mM 
EDTA, 1mM 0.5% NP40, 1 % Triton X-100, pH 7.0) supplemented with a protease 
inhibitor cocktail (Roche). Immunoblotting and immunoprecipitation (IP) were performed 
as previously described.  
 
Immunofluorescence staining 
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Cells were grown on coverslips and fixed with 7:3 Methanol/acetone or 4% 
paraformaldehyde at RT for 10 min followed by air drying for 10 min.  Blocking was 
carried out for 20 min with 5% BSA/PBS, and incubated with primary antibody overnight 
at 4°C in 5% bovine serum albumin/PBS. Controls included cells stained with primary 
antibody omitted. Antibody binding was visualized using fluorescein isothiocyanate-
conjugated donkey anti-goat IgG secondary antibody (Santa Cruz, USA). Slides were 
viewed using an Imaging Systems inverted IX71 microscope (Olympus, Tokyo, Japan) 
configured for multifluorescence image capture. Images were acquired using SimplePCI 
imaging software (Compix, Hamamatsu, PA). For PC2 surface expression, images were 
quantified by identifying regions of surface staining on individual cells (n=30 for each 
transfection) and determining surface staining intensity using ImageJ analysis software 
(NIH).  
 
siRNA knockdown 
Isoform-specific siRNA to pig SNX3 was chemically synthesized by Ambion (Austin, TX) 
according to the following sequence: (VHQVH ¶-GCUUCGAAGUGAAUUAGAATT-¶
antisense 5'-UUCUAAUUCACUUCGAAGCCA-¶. This targets a sequence common to 
isoform 1, 3, 4 and 5 (Figure 1c).  A scrambled negative control siRNA (Silencer) was 
purchased from Ambion. For knockdown of endogenous VPS35 in LLC-PK1 cells, the 
IROORZLQJ VHTXHQFHV ZHUH V\QWKHVLVHG 936 VL51$  ¶-
UAAAGAUACAACAUCCUCUGAAGGC-¶ DQG 936 VL51$  ¶-
GCCUUCAGAGGAUGUUGUAUCUUUA-¶7UDQVIHFWLRQRIQ0VL51$LQWRFHOOV
was achieved using RNAimax reagent (Invitrogen). The efficiency of knockdown was 
assessed by immunoblotting or RT-PCR 72 h post-transfection. 
 
Cell surface biotinylation 
Cells were cultured to 90% confluence in 6 well dishes, washed three times with PBS and 
incubated for 40 min with 1 mg/ml sulpho-NHS-SC-Biotin in PBS pH 8.0 at 4°C. Cells 
were rinsed twice with PBS containing 100 mM glycine and excess biotin quenched by 
further incubation for 20 min with PBS containing 100 mM glycine and 0.1% BSA. After 
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washing twice with PBS, they were lysed in 500 µl buffer (50 mM Tris, 500 mM NaCl, 5 
mM EDTA, 1% TX-100, pH 7.5) for 1 h at 4°C. Equal amounts of cell lysate were 
incubated with 100 µl streptavidin beads overnight at 4°C. Beads were washed three times 
each with lysis buffer, high salt buffer (50 mM Tris, 500 mM NaCl, 0.1% TX-100) and 
non-salt buffer (10 mM Tris, pH 7.5) before being resuspended in 40 µl 2×SDS sample 
buffer. Samples were analysed by SDS-PAGE and western blotting using the antibodies 
described and bands quantified using a Biorad Gel Doc XR+ Imager. 
 
EndoH deglycosylation 
Following cell surface biotinylation, labelled proteins were incubated with 500 Units 
EndoH (New England Biolabs, UK) as previously described 4. 
 
Xenopus Embryo Manipulations 
Xenopus experiments were approved by the Institutional Animal Care and Use Committee 
and adhered to the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals. Embryos obtained by in vitro fertilization were maintained in 0.1x modified 
Barth medium 44 and staged following 45 . Knockdown of Vps35 was performed using an 
antisense morpholino oligomer (Vps35-MO, ¶-GGA CTG CTG GGT CGT GGG CAT 
&$7 &¶-¶ *HQH7RROV SUHYiously reported in Coudreuse et al. 26 and confirmed by 
immunoblotting using a validated Vps35 antibody (ab154647, Abcam).  Injections were 
performed at the 2-cell stage targeting a single blastomere with the contralateral side 
serving as uninjected control. Embryos were analyzed when sibling uninjected control 
embryos reached stage 40. 
 
)RU LPPXQRIOXRUHVFHQFH DQDO\VLV HPEU\RV ZHUH IL[HG LQ 'HQW¶V IL[DWLYH
(Methanol:DMSO=4:1). Xenopus embryos were then embedded in paraplast and sectioned 
at 25 Pm. Sections were probed with an antibody recognizing Xenopus PC2 (#AB9088, 
EMD Millipore, see Supplementary Figure S2 for antibody validation) and visualized by 
staining with anti-rabbit Alexa-647. Sections were counterstained with DAPI and Erythrina 
Cristagalli Lectin (ECL, Vector Laboratories) to visualize nuclei and the apical domain of 
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the proximal tubules as described previously 46. Slides were analyzed by confocal 
microscopy and apical PC2 staining was quantified using ImageJ determining the number 
of pixels within the ECL staining domain. 
 
Electrophysiology 
LLC-PK1 cells were co-transfected with a porcine VPS35-specific siRNA 1 (see sequence 
above) or porcine PC2-VSHFLILF VHQVH ¶-UGUAGUAGUACACUGGAGC-¶) siRNA 
and CD8D using Lipofectamine 2000 (Invitrogen). Transfected cells were identified using 
anti-CD8D-coated beads (DYNAL). CD8D SOXV D VFUDPEOHG VL51$ VHQVH ¶-
UUCUCCGAACGUGUCACGU-¶ 4LDJHQ were used in mock-transfected cells. 
Transfection reactions were performed in 35-mm dishes using 1Pg DNA (CD8D cDNA) 
and 40 pmoles of one or two siRNAs (VPS35 siRNA 1 or PC2 siRNA) in a total of 500 Pl 
media containing 6 Pl Lipofectamine2000. 
Immediately before each experiment, a coverslip bearing LLC-PK1 cells was removed 
from the culture plate and put into a recording chamber, which was mounted on the stage 
of a Nikon Diaphote inverted microscope. The extracellular solution was normal Tyrode 
solution containing (in mM): 135 NaCl, 5.4 KCl, 0.33 NaH2PO4, 1 MgCl2, 1.8 CaCl2, 5 
HEPES, 5.5 glucose (pH 7.4). Recording pipettes were made from capillary glass (plain; 
Fisher Scientific, Pittsburgh, PA, USA) using a micropipette puller and polisher (PP-830 
and MF-830, respectively; Narishige, Tokyo, Japan). Pipettes were back-filled with 
internal solution composed of (in mM): 100 K-aspartate, 30 KCl, 0.3 Mg-ATP, 10 HEPES, 
10 EGTA, and 0.03 GTP (pH 7.2). Pipette resistance varied from 3±5 MȍZKHQILOOHGZLWK
this internal solution. Offset potential was corrected just before a gigaohm seal formation. 
Series resistance and capacitance transients were compensated with a Warner PC-505B 
amplifier (Warner Instrument Corp., Hamden, CT, USA) and pClamp 10.0 software (Axon 
Instrument, Foster City, CA, USA). Currents were digitized with a Digidata 1440A 
converter (Molecular Devices), filtered through an internal four-pole Bessel filter at 1 kHz, 
and sampled at 2 kHz. Inward and outward whole-cell currents were elicited by employing 
a step-pulse protocol from -100 to +100 mV every 3 seconds for 200 millisecond duration 
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from a holding potential of -60 mV. Current-voltage (I-V) curves were derived using a 
voltage step protocol ranging from -100 to +100 mV in 20-mV increments for 200 
milliseconds duration from a holding potential of -60 mV. Steady-state currents were 
averaged between 50 and 100 milliseconds. Cells with a similar diameter were selected for 
recordings, and only those cells with stable baseline currents were included in the results. 
Purified Wnt proteins were directly applied to the bath solution from a stock solution of 
100 ng/Pl.  
 
Statistics  
Data are presented as mean values ± SEM. Student's t test was used for statistical analysis 
with a p value of <0.05 indicating statistical significance. All analysis was carried out using 
Prism (Graphpad). Current traces were analyzed off-line with pClamp 10.0. All results are 
presented as means (± SE). One-way analysis of mean and variance computation was used 
to analyze data with unequal variance between each group. A probability level of 0.05 was 
considered significant. The Boltzmann equation used to plot Inormalized as a function of 
concentration and calculate EC50 as follows: y =A1-A2/1+e(x-x0)/dx + A2, where y is the 
Inormalized at a given concentration (x), A1 and A2 are the Inormalizedmax and Inormalizedmin, 
respectively, x is the given concentration, xo is the EC50, and dx is the slope factor. 
Microcal Origin 6.0 software was used to fit the data. 
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Figure legends 
Figure 1 Identification of a new SNX3 isoform and its interaction with PC2 
A. Yeast 2-hybrid screens of an E17 embryonic mouse cDNA library using a portion 
(aa799-895) of the C-terminus of human PKD2 (CT2) as bait identified a novel isoform of 
SNX3. Yeast co-transformants were retested on selective media to activate HIS3 and ADE2 
selection markers. The new isoform SNX3-102 interacted with CT2 (799-871) and full-
length CT2 (680-968) but was unaffected by mutations (4M) disrupting the coiled-coil 
domain (CC2) which mediates CT2 homodimerization. In contrast, no interaction between 
CT2 and SNX3-162 was detected.  
B. In vitro GST pull-down assays indicate that GST-SNX3-102 but not GST-SNX3-162 
bound to recombinant Thio-CT2 directly. Neither GST nor glutathione beads bound to 
Thio-CT2. 
C. Exon map showing the alternative splicing of different human isoforms of SNX3. 
Compared with the classic isoform SNX3-162, the new isoform SNX3-102 is missing exon 
3 and part of exon 4. The PX domain region is marked by the shaded bar. Numbers indicate 
the amino-acid boundaries for different exons and domains. Dotted boxes represent 
missing exons. The two isoforms were amplified independently using specific primers 
indicated by arrows on the figure. The sequence targeted by the SNX3 siRNA is indicated. 
Swiss-Prot Accession numbers: O60493 (isoform 1); O60493-2 (isoform 2); O60493-3 
(isoform 3); O60493-4 (isoform 4). 
D. Ratio of SNX3-102 versus SNX3-162 in developing mouse embryos between E10 and 
E16. The relative mRNA level of SNX3-102 level was ~ 3-5% that of SNX3-162 (set to 
100%) at each developmental stage. A similar ratio between both isoforms was found in 
mouse IMCD cells. Expression of murine SNX3-102 mRNA showed a trend to increase 
during development. The relative mRNA level was calculated in relation to that of HPRT. 
 
Figure 2 SNX3-162 binds to the N-terminus of PC2 via the core retromer protein 
VPS35 
A. Co-immunoprecipitation assays between full-length HA-PC2 and myc-SNX3-102 or 
myc-SNX3-162 in transfected HEK293 cells. Both isoforms bound to full-length PC2 in 
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both directions. 
B. A small plasma membrane pool of GFP-SNX3-102 (70% transfected cells show 
membrane expression) could be visualized in MDCK II cells (arrow) whereas GFP-SNX3-
162 did not show clear surface expression under same conditions (top panel). GFP-SNX3-
102 co-localized with the endocytosis-associated protein AP2 (middle panel). In contrast, 
GFP-SNX3-162 co-localized with the early endosome marker, EEA1 (bottom panel). 
Similar findings were observed in HeLA, MDCK and IMCD3 cells (not shown). 
C. GST pull-down assays from cell lysates showing that GST-SNX3-102 but not GST-
SNX3-162 binds to endogenous clathrin and the AP2P2 subunit. Loading controls and 
binding of GST fusion proteins to beads is showed in the lower panels. The doublet bands 
observed for AP2P2 could represent different splice forms or phosphorylation status. 
D. Co-immunoprecipitation assays between full-length HA-PC2 and full length GFP-
VPS35 in transfected HEK293 cells. VPS35 bound to full-length PC2 in both directions. 
E. Immunoprecipitation of endogenous PC2 by the PC2 mAb YCE2 (Santa Cruz, USA) 
from LLCPK1 cells co-immunoprecipitated endogenous VPS35 and SNX3 in the same 
complex. An irrelevant mIgG2A antibody was used as a negative control. 
F. siRNA knockdown of VPS35 abolished the binding of SNX3 to endogenous PC2 in co-
IP assays from LLCPK1 cells. A scrambled siRNA control had no effect on this interaction. 
An irrelevant mIgG2A antibody was used as a negative control for the IP. 
G. GST pull-down assays from HEK293 cell lysates showing that a recombinant GST 
protein encoding the N-terminus of PC2 (GST-NT2, aa1-223) but not the C-terminus of 
PC2 (GST-CT2, aa 680-968) bound to co-expressed GFP-VPS35. Binding of the C-
terminus of PC1 (GST-CT1, aa 4107-4303) to GFP-VPS35 was also detected. 
H. In vitro GST binding assays using purified GST-NT2 and recombinant FLAG-
VPS35/26/29-His proteins confirmed a direct interaction between both proteins. GST 
protein was used as a negative control. 
I. In vitro binding between recombinant MBP-CT1 and recombinant FLAG-VPS35/26/29-
His proteins indicate a direct interaction between the two proteins. MBP protein was used 
as a negative control. 
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Figure 3 Knockdown of SNX3 or VPS35 leads to increased surface expression of 
endogenous PC1 and PC2 in LLC-PK1 cells and in Xenopus pronephric tubules 
A. Surface expression of endogenous PC1 and PC2 in LLC-PK1 cells was increased 
following selective knockdown of SNX3 or VPS35 siRNA (20nM) compared to a 
scrambled control siRNA. Surface biotinylated PC1 and PC2 was compared to total 
PC1/PC2. Na+-K+-ATPase and calnexin were used as positive and negative controls 
respectively for surface biotinylation. 
B. The ratio of biotinylated/total PC1 calculated from four independent experiments 
showed a significant increase following SNX3 (p<0.05) and VPS35 (P<0.05) knockdown: 
Scrambled siRNA = 0.139 ± 0.047; SNX3 siRNA = 0.306 ± 0.048; VPS35 siRNA = 0.600 
± 0.171. Similarly, a significant increase in biotinylated PC2 was observed following SNX3 
(p<0.05) and VPS35 (P<0.001) knockdown in triplicate experiments: Scrambled siRNA = 
0.235 ± 0.035; SNX3 siRNA = 0.527 ± 0.076; VPS35 siRNA = 1.289 ± 0.038. The increase 
in biotinylated PC1 and PC2 was quantitatively greater following VPS35 knockdown 
compared to SNX3 despite a more complete inhibition of the latter. 
C. EndoH digestion of surface biotinylated proteins in LLCPK1 cells. While PC1 and Na+ 
K+ ATPase were EndoH resistant, surface labelled PC2 was EndoH sensitive. Calnexin, an 
ER resident protein acts as a negative control for the biotinylation assay. Representative 
experiment of two shown. 
D. Endogenous PC2 expression in LLC-PK1 cells detected by widefield 
immunofluorescence microscopy using a specific PC2 antibody (g20, Santa Cruz, USA) 
as previously described 18. A proportion of PC2 was detectable in the lateral plasma 
membrane as well as in primary cilia co-labelled with an antibody to acetylated tubulin 
(arrows). Left - A clear increase in plasma membrane PC2 staining was observed following 
knockdown of SNX3 or VPS35 relative to untransfected controls or cells transfected with 
a scrambled siRNA. Right - No change in cilia PC2 expression was detectable. Images are 
representative of 3 separate experiments. 
E. Surface staining intensity was calculated as a percentage relative to control 
untransfected cells and expressed as bar diagrams. Left - A significant increase in surface 
expression of PC2 was seen following SNX3 and VPS35 knockdown (p<0.005): 
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Scrambled siRNA = -5.54% ± 1.68, n=30; SNX3 siRNA = 14.74% ± 4.24, n=30; VPS35 
siRNA = 35.01% ± 2.28, n=30. Right - there was no significant difference in cilia 
localization of PC2: control siRNA = 92.88 ± 4.52, n=50; Scrambled siRNA = 92.42% ± 
7.58, n=32; SNX3 siRNA = 93.3% ± 3.88, n=31; VPS35 siRNA = 96.43% ± 3.57, n=39. 
F. Uninjected Xenopus controls (i, ii) and embryos injected unilaterally with a total of 1.6 
pmol Vps34-MO (iii, iv) were analyzed at stage 40 by PC2 immunofluorescence (red). ECL 
was used to visualize the apical side of the proximal tubules (green) and nuclei were 
counterstained with DAPI (blue). Images were analyzed by confocal microscopy and all 
three z-planes are shown. The white lines indicate the position used for x,z and y,z planes, 
respectively.  
G. Bar diagram to quantify the apical pixel intensity of PC2 staining. Error bars represent 
VWDQGDUG GHYLDWLRQ DQG VWDWLVWLFDO VLJQLILFDQFH ZDV GHWHUPLQHG XVLQJ 6WXGHQW¶V W-test (* 
p<0.05). Note that the pronephric tubules of Vps35 morphants are dilated, which is likely 
due to the effect of the retromer complex on the secretion of Wnt ligands and their role in 
kidney tubulogenesis 11, 26. 
 
Figure 4 Depletion of VPS35 increases functional expression of PC2  
A-L. Current-voltage (I-V, A,D,G, and J), time course (B,E,H, and K), and representative 
step whole cell currents (C,F,I,I, and L) in cells transfected with a scrambled control siRNA 
(mock, n=6, A), PC2-specific siRNA (n=8, B), VPS35-specific siRNA (n=10, C), or 
VPS35- and PC2-specific siRNAs (n=8, D) in the presence (red IV-curves) or absence 
(black I-V curves) of 500ng/ml Wnt9b in the extracellular solution. Outward currents are 
shown in blue and inward currents are shown in black in time course experiments. Currents 
were blocked by the addition of 100 PM La3+ added in the extracellular solution at the 
indicated time points. I-V curves were taken at 4-5 min after the addition of Wnt9b, when 
currents were stable and towards the end of each pulse (195 ms). 
M-N. Summary data of outward (M, at +100mV, blue) and inward current densities (N, -
100mV, black) in all four groups. **, indicates p<0.001, ***, indicates p<0.0005. 
(O). Total cell capacitance in pF in all four groups. ns, indicates p>0.005  
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Figure 5 Model of SNX3 and retromer regulated PC1/PC2 trafficking and recycling 
to the PM 
A sequential model of PC2 sorting by the two SNX3 isoforms is displayed. SNX3-102 
mediates surface PC2 retrieval and clustering in clathrin-coated vesicles by binding both 
to surface PC2 and AP2/clathrin. A direct interaction between PC1 and AP2/ARRB1 
mediated through the PLAT domain has also been reported 41. PC1/ PC2 are then delivered 
to early endosomes where they can bind to SNX3-162 indirectly via VPS35 to the retromer 
complex. Sorting of different pools of endosomal PC1/PC2 for recycling to the plasma 
membrane, retrograde transport to the TGN (retromer) or to lysosomes for degradation 
takes place here.  
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S. Figure-1 Sequence analysis of novel isoform SNX3(102).  
A. Nucleotide sequence of mouse SNX-162 isoform 1 (RefSeq: NM_017472) with amino acid 
translation (RefSeq: NP_059500, UniProt: Q78ZM0). Alternating exons are depicted in blue.  
B. Nucleotide sequence of the novel mouse SNX3-102 isoform isolated and sequenced from 
DQ(HPEU\RQLFPRXVHF'1$OLEUDU\ZLWKDPLQRDFLG WUDQVODWLRQ7KHFU\SWLFVSOLFHVLWH
$$**LVXQGHUOLQHGLQEROG 
 
S. Figure-2 Knockdown of SNX-3, VPS35 or Pkd2 in LLC-PK1 and Xenopus 
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3&5$FWLQZDVXVHGDVDQHJDWLYHFRQWURO 
&Ratio of SNX3-102 versus SNX3-162 in several human cell lines. The relative mRNA level 
of SNX3-102 level was ~ 3-5% that of SNX3-162. The relative mRNA level was calculated in 
relation to that of HPRT. UCL93 was derived from normal human kidney whereas OX161 was 
generated from an ADPKD kidney 47. 
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S. Figure-4 Expression of PC1 and dose-response curves to Wnt5a and Wnt9b in LLC-
PK1 cells 
A. PC1 expression in LLCPK-1 cells detected by immunoblotting with a monoclonal anti-PC1 
antibody (7e12) using 50 (lane 1) or 100 Pg (lane 2) of total protein. 
B. Boltzmann curves of normalised currents in LLCPK-1 cells after Wnt5a and Wnt9b 
stimulation at two different voltages (-100mV and +100mV). (&YDOXHVIRU:QWDDUH
QJPOP9DQG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